ArticleOncogene2026
TKTL1 mediates metabolic adaptation and stress resistance in pancreatic cancer cells under nutrient-deprived conditions.
Article in Oncogene, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Pancreatic tumors frequently develop in nutrient-poor microenvironments due to impaired perfusion, forcing cancer cells to engage in metabolic adaptation for survival. This study identified the upregulation of transketolase-like 1 (TKTL1) as a nutrient-stress-responsive factor associated with metabolic adaptation of pancreatic cancer cells under amino-acid starvation, particularly glutamine scarcity. In particular, we found that TKTL1 induction was specifically observed in cancer cells and not in normal pancreatic ductal cells. Functional assays showed that TKTL1 overexpression increased proliferative capacity and tumor growth, whereas its knockdown attenuated these phenotypes and reduced cancer cell fitness under nutrient stress. Although TKTL1 exhibits weak intrinsic enzymatic activity, our data support a functional association with transketolase (TKT), accompanied by increased total transketolase activity. Protein-protein interaction assays further indicated that TKTL1 binds to TKT more prominently under nutrient deprivation than under nutrient-rich conditions. Furthermore, transcriptional analyses and NF-κB inhibition experiments suggest that TKTL1 upregulation is partially regulated by the NF-κB/p50 axis. Together, these findings are consistent with a model in which TKTL1 contributes to metabolic adaptation and stress tolerance in nutrient-deprived pancreatic cancer cells, in part through interaction with TKT, and suggest that the TKTL1 axis may represent a context-dependent therapeutic target in nutrient-limited tumors.
Indexed as
Identifiers
42533116What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.